In 2005, four groups (somewhat) independently demonstrated that mutation of JAK2 to JAK2V617F is found in the vast majority of patients with PV and half of patients with the other two major MPNs, ET and PMF [55,57,58,59]. The gene discussed is JAK2; the disease is essential thrombocythemia.